Dose-dependent effects of muIL-13Rα2, a potent IL-13 neutraliser, on the phenotype of an acute allergic airways inflammation model in BALB/c mice Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004
Transgenic mice overexpressing IL-18 display increased IL-13 in the airways but no changes of the airway hyperresponsiveness in a murine model of late-phase asthma: evidence for a dual role of IL-18 on mucosal Th1/Th2 responses Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002
Endotoxin interferes with allergy-induced airway inflammation in mice Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002
Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018
Estrogen protects against airway inflammation via upregulation of SLPI and downregulation of IL-33 Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
CCL6 produced by eosinophils drives allergic airway inflammation in mice Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019
AQP5 role in ovalbumin-induced airway inflammation and secretion of MUC5AC in mice Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011
Imiquimod attenuate airway inflammation and decrease the expression of TARC in allergic asthmatic mice Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006
Over-expression of SIGIRR attenuates TLR 4,5,9-mediated immune responses in human airway epithelial cells Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009
Farm dust decreases Th2 driven allergic airway inflammation in mice: A role for airway TLR2 and TLR4? Source: Annual Congress 2011 - T-cell subsets Year: 2011
High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
Antisense-induced local blockade of T-bet expression leads to airway inflammation in rats Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006
Overproduction of mature IL-18 induces IL-13 producing CD4+Tcells in the lungs, and results in airway hyperresponsiveness and pulmonary inflammation in Balb/c mice Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019
TLR4 mediates LPS-induced mucus hypersecretion in rat airway Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007
Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018
Overexpression of peroxiredoxin 6 protect mice from ovalbumin-induced airway inflammation and hypersecretion of MUC5AC by reducing ROS levels Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011
Increased susceptibility to airway allergic responses in CD40 deficient mice Source: Eur Respir J 2002; 20: Suppl. 38, 567s Year: 2002